1. Home
  2. EVTV vs EVAX Comparison

EVTV vs EVAX Comparison

Compare EVTV & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Envirotech Vehicles Inc.

EVTV

Envirotech Vehicles Inc.

HOLD

Current Price

$0.45

Market Cap

2.0M

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$4.70

Market Cap

42.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTV
EVAX
Founded
2012
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0M
42.7M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
EVTV
EVAX
Price
$0.45
$4.70
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.33
AVG Volume (30 Days)
2.1M
107.1K
Earning Date
11-20-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,696,856.00
$7,650,000.00
Revenue This Year
N/A
$128.77
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
113.69
132.17
52 Week Low
$0.40
$1.20
52 Week High
$14.00
$12.15

Technical Indicators

Market Signals
Indicator
EVTV
EVAX
Relative Strength Index (RSI) 22.09 40.15
Support Level $0.40 $4.60
Resistance Level $0.52 $6.70
Average True Range (ATR) 0.14 0.54
MACD -0.07 -0.13
Stochastic Oscillator 4.91 5.71

Price Performance

Historical Comparison
EVTV
EVAX

About EVTV Envirotech Vehicles Inc.

Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: